Second-generation MFC and NGF have demonstrated a good correlation when tumor burden is relatively high (PR, VGPR, CR), but approximately 25% of patients with MRD-negative status by conventional MFC became MRD-positive when they were assessed by NGF. This evidence concerns the gene NGF and neoplasm.